Live News EQUITY FLASH L impact Oct 27, 2026, 12:31 PM UTC Rumi Therapeutics Announces Licensing Agreement With Enthorin Therapeutics The agreement concerns RTX-7340, an IND-ready PDE2 inhibitor for Fragile X syndrome. SquawkNews Desk